Picture of Pacific Biosciences Of California logo

PACB Pacific Biosciences Of California Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Annual cashflow statement for Pacific Biosciences Of California, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-84.129.4-181-314-307
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1.56-13.613594.698.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3-2.7621-54-59
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-78.319.5-111-263-259
Capital Expenditures-2.84-1.04-5.93-16.9-8.84
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items64.9-218-67313313.4
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities62-219-6791164.6
Financing Cash Flow Items1834-52.2-93.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities26.52521,1709.62109
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10.352380-138-146